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Major depressive disorder is one of the most common and burdensome 
psychiatric disorders. Many individuals still experience symptoms despite 
pharmacological treatment. Breathing techniques have shown potential for stress, 
depression, and anxiety reduction. A second promising treatment are mindfulness-based 
interventions, which have been shown to effectively decrease depression with fewer side 
effects than pharmacological agents. Both interventions are accessible via remote 
instruction. This study will investigate the effect of Sudarshan Kriya Yoga breathwork on 
depression symptoms. Using a prospective, randomized controlled trial, subjects will 
receive Sudarshan Kriya Yoga, Mindfulness Based Stress Reduction, or standard care for 
8-weeks. We will measure changes in depressive symptoms using two validated 
depression inventories and will examine their effects on selected brain regions using 
resting-state functional magnetic resonance imaging. These results may guide an 
integrative approach for depression, expanding current options through a low-cost, low-
risk, and accessible behavioral intervention adjunctive to concurrent pharmacological 









CHAPTER 1: INTRODUCTION 
1.1 Background 
1.1.1 Depression Epidemiology and Recurrence 
 To date, more than 264 million people suffer from major depressive disorder 
(MDD), accounting for 22.8% of the global burden of disease.1 MDD is pervasive across 
age groups, ethnicities and socioeconomic statuses.2 Beyond the potential to be disabling 
psychologically, depression is associated with reduced quality of life, greater health 
comorbidities, and excess mortality.3,4 Further, there is a high likelihood of depression 
recurrence following completion of traditional pharmacological approaches.5 
1.1.2 Clinical Definition and Diagnostic Criteria  
 MDD is clinically defined in patients with a history of at least one major 
depressive episode without mania or hypomania. According to the Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-V), a major depressive 
episode consists of five or more of the following symptoms, one of which must be either 
depressed mood or anhedonia: insomnia or hypersomnia, appetite decrease or increase, 
unintentional weight loss or gain, psychomotor retardation or agitation, fatigue, poor 
concentration, excessive thoughts of worthlessness or guilt, and recurrent thoughts 
concerning death or suicide.6 The symptoms must all be present within the same two-
week period and reflect a significant change from prior baseline functioning. Lastly, the 
diagnosis of MDD is reached when excluding other disorders such as delusional disorder 
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or schizophrenia, and the symptoms must cause a significant impairment in social, 
occupational, or other areas of functioning.  
1.1.3 Depression: Goals of Treatment & Initial Treatment Options  
 When considering the goals of treatment, it is important to distinguish two 
concepts: response and remission. Based on a clinician rated depression scale, response is 
considered improvement  50% from baseline depression rating score, while remission is 
achieved once the overall depressive syndrome is concluded. Initial treatment aims for 
complete depressive symptom remission and return to baseline functioning.7,8 
While both psychotherapy and pharmacotherapy are validated options for 
treatment, most often antidepressants are chosen as first line management for MDD.9-12 
Selective Serotonin Reuptake Inhibitors (SSRIs) predominate and are the most widely 
prescribed class of antidepressants.9,13 One reason for their frequent implementation is 
that antidepressants have been shown to be effective in multiple meta-analyses of 
randomized controlled trials over years of research14-17 and thus accepted into practice 
guidelines.18,19 From a patient perspective, contributing factors such as cost, 
comorbidities, and psychosocial stressors must be taken into account when considering 
these two treatment options.  
Although over a thousand randomized clinical trials have been conducted with 
antidepressants, there are concerns regarding comprehensive study design elements and 
antidepressant efficacy, safety and tolerability.20 Improper interpretation of statistical 
significance, publication bias21, manipulated study design, selection bias of study 
populations, short term follow-up which excludes discussion of potential long term 
adverse effects, and focus on clinically non-relevant outcomes have the potential to 
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construct a false sense of security regarding antidepressant effectiveness and tolerability. 
Furthermore, SSRIs have side effects such as sexual dysfunction, lethargy, drowsiness, 
nausea, weight gain and alteration of normal sleep pattern which reduce compliances.22 
Conversely, the antidepressant can be changed to a different class, which prolongs the 
time for the new drug to reach effectiveness and thus the amount of time it takes for the 
patient to achieve response and remission. 
Patients may discontinue their antidepressants suddenly following remission 
which carries a risk of relapse and discontinuation syndrome.23 These withdrawal effects 
may appear within hours to days after cessation, and include dizziness, gastrointestinal 
complaints, lethargy, flu-like symptoms, irritability and anxiety.24 By extension, these 
distressing symptoms may result in unnecessary and costly testing if not recognized as 
symptoms of discontinuation.25 These findings illustrate the necessity of exploring 
whether we can supplement antidepressant pharmacological therapy in order to improve 
antidepressant response, limited adverse effects, and achieve remission.   
1.1.4 Introduction to Sudarshan Kriya Yoga   
Sudarshan Kriya Yoga (SKY) is a type of yogic breathwork consisting of three 
types of breath: ujjayi, bhastrika, and Sudarshan Kriya, in addition to a brief chanting 
component.26 There is a rest period of approximately 20 seconds following each of the 
four stages of breathing. Ujjayi, also called “victorious breath”, consists of 2-4 cycles per 
minute (cpm) of nostril breathing with a slight constriction of the laryngeal muscles to 
produce a shallow, ocean-like sound when breathing. Each cycle consists of 4 count 
inspiration, 4 count end-inspiration hold, 6 count expiration, and 2 count expiration hold, 
complemented with hand placement on the lower belly, ribs or upper back. The second 
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component called Bhastrika or bellows breathing is a forceful technique where air is 
actively inhaled and exhaled with the use of abdominal muscles at approximately 15-20 
cpm. Next, participants typically chant the word “om” three times on a long exhale with a 
15 second rest period after each chant. The last breathing component of SKY is 
Sudarshan Kriya, which unlike the first component has no end expiration or end 
inhalation breath holding. Inhalation and exhalation phases are equal in duration and no 
airway resistance is used, unlike ujjayi. Sudarshan Kriya has three different rates of 
breathing: slow (8-14 cycles per minute, cpm), medium (30 cpm) and rapid (150-180 
cpm) (See Appendix A). The number of breaths and duration of cycles differ between in 
class sessions and at home individual practice. This session typically closes with kriya, a 
slow, steady set of 8-10 slow cycles with a 5-minute period of rest in the supine position 
to prevent dizziness and lightheadedness when standing up.  
Different types of yoga incorporate mindfulness meditations, breathwork and 
physical postures or asanas. The protocol for SKY in our proposed study will not require 
physical movement, which makes it accessible to most ability levels. SKY has been 
utilized as an intervention for anxiety, stress and depression.26 The exact mechanism 
through which breathwork achieves beneficial effects is unknown, but some studies 
highlight its influence on cardiovascular parameters, autonomic variability, and 
cerebrovascular hemodynamics.27-29 SKY holds promise as an adjunctive treatment 
option for MDD given its ease of use, accessibility, lack of adverse effects, as well as 
potential long-term benefits even after concluding the intervention.  
 5 
1.1.5 Introduction to Mindfulness Based Stress Reduction 
A widely accepted operational definition of mindfulness-based interventions 
(MBIs) consists of two core concepts. Self-regulation of attention on the current moment 
complements an overall view of openness and acceptance regarding the present moment 
which includes any intrusive or distressing thoughts, emotions or memories.30 Attention 
is self-regulated and maintained in a non-ruminating and nonreactive way, which is 
beneficial for the depressed patient population, as rumination is a prevalent symptom.  
Mindfulness Based Stress Reduction (MBSR) was the first MBI to gain empirical 
support.31 The three components of MBSR are full body scan, sitting meditation, and 
Hatha yoga. The combination of mental and physiologic components promote stability of 
mood, lessen reflexive rumination, and potentially extend periods of depressive remission 
in a depressed patient population.32,33   
 1.1.6 Introduction to the Default Mode Network 
The default mode network (DMN) is an interconnected neurological circuit shown 
to be active during times of self-referential thought and non-task-based states.34 It is made 
up of discrete areas of the brain: a central midline core made of the posterior cingulate 
cortex (PCC) and the medial prefrontal cortex (mPFC) which communicates with two 
subnetworks: the dorsal medial prefrontal cortex (dMPFC) subsystem and the medial 
temporal lobe (MTL) subsystem.35 The DMN has also been associated with self-
reflection on one’s own emotional state, which would support its relationship with 
psychological disorders and over time with depressive rumination.36,37 The DMN is the 
brain’s intrinsic, ongoing activity that is active when participants are not focused on the 
outside world, such as mind wandering.38 The DMN has been an area of interest in 
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depression because depressive, self-focused thoughts may correlate with the baseline 
within-network DMN hyperconnectivity that is uniquely seen in depressed patients. 39 
1.2 Statement of the Problem 
 MDD is a disabling disease typically treated with pharmacological therapy which 
has modest short-term benefit and variable long-term effectiveness. Despite use of first 
line pharmacotherapy, many individuals still suffer from depressive episode recurrence 
and do not achieve remission. There is a clear need for interventions beyond 
pharmacology, including further validation of Mindfulness-Based Interventions such as 
Mindfulness Based Stress Reduction, and other non-pharmacological interventions. 
Sudarshan Kriya Yoga, with its emphasis on breathwork, has the potential for 
effectiveness as an adjunct therapy to antidepressants. Behavioral adjuncts may help to 
prevent escalation to high intensity therapies (such as one to one psychological therapies) 
and avoid further financial, emotional, and psychological burden within the patient 
population. 
1.3 Goals and Objectives  
 The primary aim of this study is to evaluate the antidepressant effectiveness of 
Sudarshan Kriya Yoga as adjunctive treatment for MDD in comparison to Mindfulness 
Based Stress Reduction and solely pharmacologic treatment. The secondary aim is to 
investigate potential change in functional connectivity within the DMN in mild to 
moderately depressed patients on stable pharmacological therapy who receive SKY or 
MBDR as adjuvant therapies. 
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1.4 Hypothesis   
In this study, it is hypothesized that there will be a statistically significant 
difference in depressive symptoms in subjects aged 18-65 years old with mild to 
moderate depression on stable antidepressant pharmacological therapy following an 8-
week SKY intervention as adjunctive treatment, as measured through the 17item 
Hamilton Depression Rating Scale (HAM-D17)40 (see Appendix B) and Beck Depression 
Inventory, Second Edition (BDI-II)41 (See Appendix C) compared to a group using 
MBSR as adjunctive treatment alongside pharmacologic therapy, and a third group 
continuing their pharmacological treatment only. 
To address the second aim, it is hypothesized that resting state functional 
connectivity MRI (rsfcMRI) scans will show a change in DMN functional connectivity 
(FC) as measured through BOLD signal changes when comparing baseline imaging 
obtained prior to SKY intervention to imaging acquired post-intervention. Definitely need 
to define DMN in a background section or reader will no know what this means. 
1.5 Definitions 
Resting state (fMRI scanning condition): the participant is not performing a task or 
responding to a stimulus. Instead, he/she will be awake but with eyes closed, not thinking 
about anything in particular.  
Functional connectivity: temporal associations of synchronous neural activity between 
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CHAPTER 2: LITERATURE REVIEW  
2.1 Introduction  
2.1.1 Literature Search 
 A thorough literature search was conducted by means of PubMed, Scopus, and 
The Cochrane Library from December 2020-July 2021. Studies, meta-analyses, and 
reviews relevant to the proposed study were initially based on perusing titles and 
abstracts. A final search was completed on July 6, 2021. Key terms used in each data base 
pertinent to the psychological disorder of depression included major depression, MDD, 
major depressive disorder, unipolar depression, depressive disorder, depression, and 
depressive. Studies utilizing yogic breathwork were also searched for by alternating terms 
such as pranayama, Sudarshan Kriya Yoga, SKY, breathwork, controlled breathing, and 
yoga(ic) breathing. Terms used to identify papers based on mindfulness interventions 
included mindfulness, mindful, meditation, mindfulness-based intervention, MBI, MBSR, 
mindfulness-based stress reduction, and stress reduction. Lastly, alternative terms for the 
default mode network included resting state network, DMN, default network, resting 
state, resting state connectivity, functional connectivity, and functional brain network. 
We also used terms relevant to the anatomical aspects of the default mode network such 
as posterior cingulate cortex, PCC, cingulate cortex, medial prefrontal cortex, and 
prefrontal cortex. The aforementioned search terms were used in various combinations, 
combining categories using and/or functionalities. 
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 Literature returned from the initial search (n=374) included prospective studies, 
retrospective studies, clinical trials, randomized controlled trials, meta analyses and 
systematic reviews. International studies were included in the review, but the search was 
limited to the English language only. We also used articles from reference lists of the 
studies that were selected after our initial search.  
2.2 Sudarshan Kriya Yoga and Mindfulness Based Stress Reduction 
2.2.1 Sudarshan Kriya Yoga Interventions in Depression  
 Sudarshan Kriya Yoga (SKY) has been shown to lessen the severity of stress, 
anxiety, and depression. A prospective, randomized controlled trial (RCT) focused on 
severe depression fulfilling DSM-IV criteria and had three distinct treatment arms: a 30 
minute SKY session once a day versus imipramine versus bilateral electroconvulsive 
therapy (ECT) three times per week.1 In order to isolate the effect of SKY breathwork, 
only the three breathwork phases- ujjayi, bhastrika and Sudarshan Kriya- were taught 
without mindful or relaxation techniques. The SKY arm showed a statistically significant 
67% remission rate (defined as having a Hamilton Depression Rating Scale total score < 
7), which is particularly impressive given the severity of the patients’ depression. At the 
end of 4 weeks, SKY was superior to imipramine therapy and did result in lower 
depression symptom severity.  
A majority of studies taught SKY comprehensively using breathwork with guided 
meditation and stress relieving skills. An intervention program in the United Kingdom 
recruited individuals with mild to moderate depression and anxiety disorders who were 
taught in four weekly, one-hour sessions with a certified SKY instructor.2 Intention to 
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treat analysis showed a statistically significant reduction in self-reported depression 
symptoms by 22% and reduction in anxiety by 30% (p<0.001). All statistically significant 
differences remained when performing subgroup analysis based on age groups, males 
versus females, and medication use. Another clinical trial utilized SKY breathwork with 
chanting in addition to weekly self-help groups and mindfulness tactics for 6 months in 
subjects with a primary DSM-IV diagnosis of a Mood disorder, including depression.3 In 
the depressed population, patients with and without antidepressant use both showed very 
low to absent depression symptoms following completion based on the clinician rated 
Hamilton Rating Scale for Depression (HAM-D 17) and patient completed Zung Self-
Rating Scale for Depression. The use of antidepressant medications did not seem to 
significantly affect scores, which limited possible confounders. Given that medicated 
subjects included in Group 1 were on the same dose for the past 6 months, the 
medication’s effect reached a steady plateau. Thus, SKY could be seen as the compelling 
factor that propelled improvement in depression which remained at 6 month follow-up.  
A randomized waitlist-controlled trial utilized an 8-week intervention of SKY 
breathwork with yoga, mindfulness meditation, and stress education in treatment resistant 
major depressive disorder (MDD) patients.4 Treatment resistance was defined as 
persistence of a non-psychotic, depressive episode despite  8 weeks of antidepressants. 
Intention to treat (ITT) analysis showed that participants had an average reduction in 
HAM-D17 total score of 9.77, which improved more than waitlist control (0.50). The 
study had high completion rate at 77% despite significant time requirement with many 
patients having school or work commitments during the day. To the researcher’s 
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knowledge, this was the first study to show SKY as an effective and highly tolerable 
adjuvant measure for treatment resistant depressed patients.  
2.2.2 Mindfulness Based Interventions in Depression 
It is thought that practices which center around mindfulness, termed mindfulness-
based interventions (MBIs), alleviate intense emotional states such as cyclical rumination 
common in depression.5 Clinically applied MBIs within the field of mental health include 
Kabat-Zinn’s mindfulness-based stress reduction (MBSR) and mindfulness-based 
cognitive therapy (MBCT). In a meta-analysis of MBIs for psychiatric disorders, it was 
found that MBIs were superior to no treatment and were equivalent to evidence-based 
treatments such as antidepressants.6    
 A different meta-analysis evaluated twelve RCTs (n=578) utilizing MBIs such as 
MBSR for participants meeting DSM-IV criteria for MDD or an anxiety disorder 
compared to waitlist and active controls.7 All studies had a primary outcome of change in 
symptom severity, measured through self-report and clinician rated questionnaires 
including the HAM-D17. Random effects models showed that there was a post-
intervention between-group difference in favor of MBIs on primary symptom severity 
with a medium effect size that was statistically significant (p < 0.01). Effects of MBIs on 
depression symptom severity replicated findings of a previous meta-analysis.8  
One of the most comprehensive reviews analyzed 209 trials of MBIs among 
12,145 patients with varying psychological disorders, ages, and genders.9 This meta-
analysis concluded that MBIs were more effective in lessening the severity of both 
psychological and physical symptoms when compared to waitlist, psychoeducation, 
supportive psychotherapy relaxation training and imagery, and suppression techniques.  
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When analyzing the selected studies that targeted depression, the mean effect size on 
depression was moderately strong for 5 pre-post studies and moderate for 8 waitlist-
controlled studies. Patients with baseline mild to severe depression all showed reduction 
of depression severity to mild and moderate levels respectively post-treatment based on 
the BDI-I and BDI-II. Treatment effects remained stable over follow-up periods ranging 
from 3 weeks to 3 years. These findings mirror those of a prior meta-analysis8, which 
concluded that mindfulness-based therapies showed a clinically significant large effect 
sizes that maintained through a period of follow up. 
A one-month long RCT used somatic relaxation training as an active control 
comparing the effects of mindfulness meditation (MM) modeled on MBSR protocol.10 It 
was hypothesized that both MBSR and somatic relaxation training would be beneficial in 
reducing overall stress, but only the mindfulness intervention would reduce distracting 
and ruminative thoughts. This study was included within our literature review because 
rumination is a key symptom in depression. The protocol did match MBSR in its use of 
body scan, sitting meditation, and Hatha yoga. At the conclusion of the study, unique to 
only the MM group was the significant pre-post decreases in both distractive and 
ruminative thoughts/behaviors based on the Daily Emotion Report, a self-report 
questionnaire. Thus, the MM based on MBSR showed a unique ability to lessen 
rumination and distraction, common symptoms of depression. 
2.3 Feasibility and Efficacy of Internet Based Interventions 
 In light of the current COVID-19 pandemic with understandable social distancing 
and restrictions in sizes of gatherings, technology may be the greatest ally in continuing 
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mindfulness-based interventions. In the place of face-to-face MBIs, clear direction and 
insight can still be achieved through the use of computer, smart phone, or tablet-based 
interfaces and remote, online programming. Furthermore, it is adaptable to both 
individual therapy and group therapy without posing a health risk.11  
The proposed study’s focus on depressed individuals is pertinent as well. COVID-
19 can have emotional, mental and physical health consequences as it interrupts daily 
living.12 A population-representative survey study showed that the prevalence of 
depression had increased more than three-fold during the pandemic. Furthermore, more 
severe depressive episodes during this pandemic may elevate drop-out rates from 
treatment secondary to significant loss of motivation and debilitating apathy common in 
depression, leading to inconsistent attendance.  
Of note, the same survey showed that lower income during COVID-19 was 
associated with a greater risk of depression, showing the disproportionate effect when 
having less than $5000 in savings account was correlated with a 1.5 fold increased odds 
of depressive symptoms, or 50% greater risk. As a result, resource limited communities 
are a key patient population to evaluate. And yet, they may be excluded from in person 
studies due to factors related to health disparity such as work schedules, child care, and 
transportation costs. Therefore, it is more likely that in-person studies automatically 
exclude large segments of the population. As a result, incorporation of internet-based 
interventions may strengthen outreach and incorporation of those vulnerable patient 
populations.   
In one meta-analysis of 15 RCTs studying the relationship of online MBIs with 
measures of mental health and well-being, online MBIs including MBSR had a beneficial 
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effect on depression, anxiety, mindfulness and well-being.13 This meta-analysis was the 
first to show that online MBIs strengthened aspects that pertain to greater quality of life, 
including well-being and mindfulness with a significant small effect size. A randomized 
control pilot study utilized an internet-based mindfulness program over 8 weeks to 
improve stress in adults without psychological disorders.14 Researchers adapted strategies 
from MBSR, including body scan, mindfulness meditation, and sitting meditation. 
Individuals who completed the mindfulness meditation course had a mean Perceived 
Stress Scale score of 14.44 (5.86) compared to a mean score 23.73 (9.95) at the 
beginning of the course, which was a statistically significant change (p<0.001) that 
remained at 1-month follow-up. The pre-post effect size was 1.57, which is higher than 
face-to-face MBSR and cognitive therapy courses ranging from 0.52 to 1.19 as 
mentioned within the study. While limitations include lack of a control group and lack of 
assessment of anxiety and depressive symptoms specifically, this study showed that 
online mindfulness courses seem to achieve similar results to face-to-face therapies.  
Another RCT evaluated the efficacy of unguided internet-based mindfulness 
treatment for anxiety disorders.15 The mindfulness treatment group protocol consisted of 
96 audio modules centered on sitting meditation, body scan, and mindfulness movement 
to be performed 6 days per week for 8 weeks. This was compared to an online discussion 
forum control group. Intention to treat (ITT) analysis showed that the mindfulness group 
had a larger improvement in anxiety and depressive symptoms as well as insomnia from 
baseline to after intervention. The BDI-II showed improvement in the mindfulness group 
more so than the control group. When considering the implementation of internet-based 
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mindfulness therapies in both clinical and nonclinical populations, there is support for 
efficacy and feasibility of internet-based mindfulness therapies to improve mental health.  
2.4 Depression and the Default Mode Network  
2.4.1 The Neurobiology of Depression   
 Depressed individuals tend to focus most of their attention on negative stimuli and 
excessively ruminate.16 The cognitive model of depression states that depressive 
symptoms arise from and are sustained by maladaptive thinking processes such as 
attention bias and dysfunctional attitudes. The neurobiological model of depression 
coordinates these cognitive maladaptations with brain functional connectivity and 
anatomy.17 These brain regions can be identified at baseline using fMRI, which also has 
the potential to assess treatment outcomes and effects in various trials.18    
Seeking to understand the affective aspects of self, researchers had healthy 
subjects judge a series of personality traits and how that described themselves from “not 
at all like me” to “very much like me” on a 4 point Likert scale.19 A voxel-wise analysis 
of variance (ANOVA) between valence of traits and relevance of rating showed that both 
the mPFC and posterior cingulate cortex (PCC) were preferentially activated during 
fMRI when subjects were presented with self-relevant material, regardless of positive 
versus negative valence. A prior fMRI study also found peak mPFC activity when all 
subjects without psychological disease made self-referential judgements versus 
answering general semantic knowledge questions.20 While Johnson’s study (2002) 
showed statistically significant mPFC activity with regards to self-relevant knowledge 
(p=0.05), Moran’s (2004) study extended those findings when subjects showed greater 
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mPFC activity specifically with traits that were akin to their own personality, possibly 
indicating increased self-referential thought or focus. Increased self-focus is a core 
feature in the pathology of MDD according to cognitive theory, and it has been shown to 
extend and worsen the severity of depressive episodes by perpetuating depressed thought 
and mood.21,17,22  
2.4.2 The Neurobiology of the Default Mode Network  
 The Default Mode Network (DMN) is defined as a network of brain regions that 
show coherent activity during a resting state and increased activity when individuals are 
focused on their internal state, such as self-referential thought.23 Shulman and colleagues 
(1997) first established the presence of the DMN in a meta-analysis of 9 PET-scan 
studies, which demonstrated an interconnected resting state network with task activity 
attenuation.  
Over many subsequent studies, the DMN has been established to be involved in 
many neurological disorders including major depressive disorder.24-27 Relevant to the 
proposed study, Gusnard and colleagues (2001) found that in healthy subjects, the medial 
prefrontal regions were preferentially associated with an increase in neural activity during 
internally cued conditions.28 As a result, these regions must play a large role in 
introspection. The anatomical and functional network of the DMN was further mapped in 
a series of eloquent studies undertaken by Andrews-Hanna and colleagues using 
functional connectivity MRI (fcMRI).29  
In an initial experiment, the authors found evidence for two distinct sub-networks 
working in a cohesive manner and interacting with a core region.29 These two networks 
were termed the dorsal medial prefrontal cortex (dMPFC) subsystem and the medial 
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temporal lobe (MTL) subsystem, distinct and separate as they had a correlation of near 
zero. The anterior medial prefrontal cortex (amPFC) and PCC were found to make up the 
common core of the DMN as they both showed the highest betweenness-centrality as 
defined by their statistically significant activity correlations (p<0.001).30 In the second 
experiment, regions within the dMPFC subsystem were selectively active in the Present-
Self condition, while the MTL subsystem showed much higher engagement in the Future-
Self condition. The PCC-amPFC core region demonstrated strong activation during both 
present and future-self conditions, serving as a thorough way for the two subsystems. 
Therefore, the dMPFC focuses on the current, present mental state of one’s self and 
others, while the MTL subsystem focuses on future related self-reference, and the core 
allows for coordination of both systems.  
2.4.3 Major Depressive Disorder and the Default Mode Network  
Elevated DMN functional connectivity (FC) has been shown to be a reliable 
neural marker of MDD.25,31 On baseline imaging, depressed subjects exhibit the unique 
finding of DMN hyper-connectivity.26,27 A meta-analysis compiled 27 studies analyzing 
neurological activity using resting state functional connectivity MRI (rsfcMRI).27 The 
brains of depressed patients had significant hyperconnectivity within the DMN. 
Interestingly, there was a greater likelihood of hyperconnectivity in unmedicated MDD 
patients between the DMN seeds and the hippocampus (likelihood ratio=6.01, p=0.09). 
This suggests that higher activity within the DMN reflects greater severity of depressive 
symptoms. These findings support the neurocognitive model in which brain network 
dysfunction is highly correlated to a persistent, negative mood such as in MDD.  
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One of the largest, multi site fMRI studies on MDD used a dynamic network- 
based approach, evaluating the resting state fMRI data from 460 patients with DSM-IV 
criteria of MDD and a HAM-D17 score  8.32 Following ANCOVA, the PCC and mPFC 
showed significant alteration in activity compared to healthy controls. This increase in 
activity was consistent with prior studies, which suggest a relationship between aberrant  
FC in the DMN and self-reflective, ruminative thinking contributing to depression 
severity.27,33 Rumination is a core feature of depression and consists of persistent, 
internally directed thought.21 Our proposed study will investigate not only baseline 
activity of the DMN in depressed individuals, but also following additional interventions 
to see if that baseline hyperactivity is modifiable. 
A review paper discussed whether observing change in DMN FC can serve as an 
effective tool for depression diagnosis and lead to more successful interventions.34 All the 
studies considered consistently emphasized the DMN as a key factor contributing to 
MDD and its relationship with depressive symptoms like rumination and excessive self-
referential thought. Another early fMRI study demonstrated that individuals with MDD 
had an elevated resting state subgenual cingulate and DMN FC while resting quietly as 
compared to health controls.35 Within group correlational independent component 
analysis (ICA) demonstrated enhanced subgenual FC associated with greater lengths of 
depressive episodes, reinforcing a possible relationship between brain FC and severity of 
psychological disease. Our study will expand upon these findings by analyzing fMRI 
scans with change in depression symptoms following interventions.  
Researchers quantified resting state connectivity within three distinct resting state 
brain networks, including the DMN, in unmedicated patients with MDD (HAM-D17  
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18) compared to non-depressed controls (HAM-D17  7).36 Patients suffering from 
depression had enhanced connectivity within the DMN and ANCOVA analysis using sex, 
age and education as covariates and did not contribute to the model despite significant 
between-group differences. This study once again implicated increased resting-state 
DMN FC as indicative of more self-focused thinking and strengthened the potential to 
use FC as a marker for depression severity both before and after treatment, as in our 
planned study.  
2.4.4 Rumination and the Default Mode Network  
Depressive rumination is defined as a persistent, self-reflective, and unintended 
focus on depressive distress symptoms, causes and outcomes. It is reliably associated 
with MDD with both adaptive and maladaptive components.21,37 The extent of rumination 
is even predictive of future depressive symptoms over time and risk of relapse.38,39 A 
narrative review of 94 studies of resting state brain network function in MDD found that  
the DMN reliably showed connectivity alterations when compared to individuals without 
mood disorders.40  
Berman and colleagues used seed-based fMRI analysis with the PCC and mPFC 
to evaluate rumination and the strength of association with DMN.41 Again, DMN 
connectivity with those brain regions was related to rumination (p < 0.005). To rule out 
possible contributions from the depressive subscoring used in the Ruminative Responses 
Scale (RRS), focused analysis of connectivity scores from the brooding component of the 
RRS still resulted in a positive relationship (r= 0.19, p < 0.05). The main effect of group 
did not drive the correlation between RRS scores and PCC FC, just as it was when using 
the two-sample t-tests for the functionally defined regions of interest. The study was 
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strengthened through its consistent fMRI analytical protocol with two well established 
core brain regions of the DMN.29  
One meta-analysis of 14 studies explored the relationship between brain regions 
and rumination within neuro-imaging studies, which was previously lacking.42 Prior 
conclusions had been unclear, possibly due to inconsistency in sample sizes, various 
demographic variables, and varied individual clinical features of subjects. What had been 
clear throughout prior studies though was a unique relationship between rumination and 
self-referential processing as signified through increased activity of cortical midline 
structures in depressed individuals.43-45 The PCC and amPFC demonstrated highest 
activation after rumination induction. Hyperactivation specifically within the DMN core 
and dmPFC subsystem was associated with introspection and ruminative thought.46  
This meta-analysis also helped to clarify the temporal aspect of ruminative 
thoughts.42 The DMN core regions (amPFC and PCC) and dmPFC subsystem were 
persistently activated when ruminating, while the MTL subsystem was not activated. 
According to Andrews-Hanna (2010), the MTL subsystem is associated with 
autobiographical recall while the dmPFC focuses on thinking about one or another 
person’s current mentation. The findings support that rumination in depressed subjects 
center negative thoughts regarding their own present mental states and environment 
rather than the future. Therefore, mindfulness-based interventions which focus on the 
present moment and associated emotions may be of benefit for those with MDD.  
2.4.5 Other Associated Variables   
 Alterations in DMN FC are also present in those who are at high risk to develop 
depression47,48 and are present in depressed individuals regardless of age.49,50 A study 
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used fMRI to evaluate 111 individuals aged 11-60 years old at high and low familial risk 
for depression, a part of a three-generational longitudinal cohort study of familial 
depression that began in 1982.47 If first generation subjects did have MDD, then 
subsequent generations were considered high risk. ICA showed that individuals at high 
risk had increased DMN connectivity, especially within the PCC, precuneus, and mPFC. 
Individuals at low risk showed no areas of increased activity within the DMN. In another 
study, resting state FC MRI evaluated connectivity changes within first episode, 
treatment naïve depressed individuals.48 Combined regional-wise FC analysis showed 
aberrant connectivity between the mPFC and PCC. Both regions are associated with 
aberrant executive control and emotion processing.51  
Depression can also occur in the extremes of age. A case-control study examined 
FC of 306 school aged children aged 8 years or older with a history of preschool onset 
depression (PO-MDD).49 Using the PCC as seed region, rsfcMRI scans showed that 
children with known PO-MDD had significantly increased connectivity between the PCC 
and cortical midline regions such as the mPFC. This study replicated findings from other 
studies in adults with MDD.36,41,42 A different study focused on a population of 
unmedicated individuals aged 60 or older with MDD before and after escitalopram.52 
There was no correlation between DMN FC and treatment response based on change in 
MADRS scores. However, at baseline, late life depressed patients did exhibit heightened 
FC within the DMN PCC seed region and the left precuneus. Across the ages, there is a 
consistent, unique finding of increased resting state DMN FC within depressed 
individuals. Our study incorporates DMN FC as a secondary outcome to evaluate 
potential change through various interventions, pharmacological or otherwise.  
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2.5 Nonpharmacological Interventions and the Default Mode Network    
2.5.1 Sudarshan Kriya Yoga and Default Mode Network Functional 
Connectivity 
Despite a focused and exhaustive search on various databases, no articles were 
found linking the DMN with SKY specific interventions. 
2.5.2 Mindfulness Based Interventions and Default Mode Network Functional 
Connectivity 
As described previously, the DMN is a functionally distinct network of brain 
regions with coherent activity at rest.26,29,53 The DMN has been associated with 
attentional processes in the brain including fluctuations in attentional control, or mind-
wandering.54 Mind wandering, defined as interruption of focused thought with task 
unrelated thought, is associated with and supported by the DMN.55 The DMN is also the 
functional network associated with self-referential thinking. Self-referential thinking has 
been defined as examining external stimuli as strongly related to oneself or persona, such 
as evaluating the degree to which personality traits or certain words describe oneself.56-58  
Interventions which aim at limiting mind wandering might lessen depressive 
rumination over time. Mindfulness itself is characterized by self-regulated present 
centered awareness.59 It is the key component in clinically applied MBSR which may 
reduce mind wandering, as it brings the participant fully into the present moment. 
A cross-sectional study investigated DMN activity in long term meditators versus 
those who were meditation naïve following a mindful meditation (MM) intervention, 
matching MBSR core tenants.54 There was markedly reduced functional connectivity in 
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the PCC and mPFC seed regions in meditators versus controls (p < 0.05). Meditators also 
subjectively reported less mind wandering experiences, which was associated with 
lowered DMN activity. Mindfulness practices may specifically alter DMN activity and 
thus should be evaluated clinically as a potential nonpharmacological avenue of treatment 
for depression, as in this proposed study.60  
2.5.3 Antidepressants and Default Mode Network Functional Connectivity 
 Recent studies utilizing antidepressants to treat MDD have evaluated treatment 
efficacy not only subjectively based on depressive symptom severity, but also changes in 
DMN activity. In a systemic review, 11 studies focused specifically on MDD and all 
showed baseline DMN hyperconnectivity, which is in line with a recent meta-
analysis.27,61  Within this review,  an 8-week clinical trial assessed the effects of 
escitalopram on emotion processing and regulation within moderate-severe MDD.62 A 
repeated-measure ANOVA confirmed that MDD patients had increased amygdala 
activation relative to HCs when anticipating negative stimuli. MDD individuals also 
showed heightened prefrontal activation when passively viewing negative pictures which 
was attenuated following antidepressant treatment, indicating that DMN FC is at least in 
part modifiable. However, the aforementioned conclusion cannot be considered a causal 
relationship because emotion regulation strategies were not assessed prior to this study.  
Researchers studied the effect of a 12-week course of different antidepressants on 
DMN FC in depressed individuals.63 Group ICA of imaging showed increased FC within 
the two subnetworks of the DMN of depressed individuals, consistent with prior 
studies.35,64 Researchers also found that increased DMN dominance was associated with 
higher levels of maladaptive rumination and lower dominance with adaptive, reflective 
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rumination.64 The mPFC hyperconnectivity persisted in recovered depressed individuals, 
possibly relating to the high rate of relapse in depression given this persistent activity 
despite antidepressant treatment with symptomatic improvement.  
In a prospective, double blind, placebo-controlled trial, Posner and colleagues 
evaluated duloxetine’s effect on DMN FC within individuals with dysthymic disorder 
(DD) compared to placebo control group.65 Dysthymic disorder is differentiated from 
MDD through experience of less severe depression symptoms for at least 2 years. 
However, both disorders involve excessive rumination.39 Individuals with DD had at 
baseline greater DMN connection density using the PCC as seed in whole brain resting 
state FC maps. Post hoc analysis within DD individuals showed that they had a 
statistically significant decrease in DMN connection density, so much so that it was at a 
level comparable to healthy controls, indicating normalization of DMN connectivity. 
Therefore, DMN FC could be used in future studies, such as this proposed RCT, as a 
neural correlate to monitor progression of depression. 
In the aforementioned study, there was no statistically significant relationship 
found between normalization of DMN FC and reduction in depressive symptoms as 
measured by the Hamilton Depression Rating Scale, 24 Item (HAMD-24). There is a 
need for studies to further pursue this relationship between depressive symptoms and 
DMN activity rigorously and specifically to assess for possible correlation, which is what 
this proposed study hopes to contribute to.   
2.6 Relevant Methodology  
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 This section of the literature review below details a review of studies concerning 
relevant methodology used to validate our proposed study design, variables and outcome 
measures. A detailed explanation of proposed study methods can be found in Chapter 3. 
2.6.1 Study Design and Setting 
 The proposed study will be a prospective, randomized controlled trial (RCT) 
primarily examining change in depression symptom severity in adult patients with mild-
moderate MDD. Diagnosis will be based on self-rated and clinician rated questionnaires 
comparing three randomized groups. An experimental treatment group will participate in 
SKY, which is our primary exposure, along with continuation of their standard 
antidepressant regimen. A second adjunctive care group will use MBSR and their 
standard antidepressant treatment. Lastly, the standard care control group will continue 
antidepressant medications only. As a secondary aim, we will use resting state functional 
connectivity MRI (rsfcMRI) to determine changes in functional connectivity (FC) in the 
DMN both within and between the three participant groups.  
RCTs are considered the gold standard for clinical research as the use of 
randomization eliminates potential bias inherent to other study designs. The prospective 
nature of this study enables researchers to analyze a causal relationship between 
interventions and outcomes. We chose not to use waitlist or placebo as our control 
condition in this study. It would be unethical to require MDD patients to stop 
antidepressants given the risk of discontinuation syndrome. Continuing a stable dose of 
antidepressants also reduces the risk of rebound phenomenon, where patients experience 
either higher rates of relapse or especially severe episodes of relapse following 
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discontinuation.66 Therefore, our control group will continue their antidepressants at a 
stable dose without any adjunctive treatment. 
Although antidepressant medications in combination with nonpharmacological 
therapy are recommended as first line for MDD, our study seeks to investigate whether 
additional interventions- SKY and MBSR- will be beneficial. We will take potential 
confounders into consideration, such as sex, age, and education level.67-69 The equipoise 
principle of RCTs is fulfilled, as each group holds equal potential for depression severity 
reduction without superiority.70 We seek to find effective and tolerable adjunctive 
treatments in addition to pharmacological therapy that promote improved rates of 
response and ultimate remission of depressive symptoms. 
The study will recruit patients from the Yale University Undergraduate and 
Graduate campuses as well as specialty community outpatient clinics such as the 
Connecticut Mental Health Center and the Cornell Scott-Hill Health Center. These sites 
were chosen in order to reach a broader selection of participants with diverse 
socioeconomic, ethnic, and health care access backgrounds.  
Participants will be recruited through flyer callouts, posted throughout Yale 
University Undergraduate and Graduate campuses to advertise to the university student 
population (See Appendix D). These recruitment flyers will also be posted at outpatient 
clinics to engage the community, specifically the Connecticut Mental Health Center, as 
well as the Cornell Scott-Hill Health Center. This does have the potential limitation of 
selection bias, as it includes mainly patients who are highly motivated and already 
connected to care at these clinics. However, this select group of patients are most able to 
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benefit from the proposed interventions as they require high compliance, and thus this 
limitation is acceptable.  
2.6.2 Selection of Interventions   
Given the high rate of recurrence of depressive symptoms despite adequate 
pharmacological treatment with or without psychotherapy, this study will focus on two 
adjunctive treatments to pharmacotherapy when treating MDD: Sudarshan Kriya Yoga 
(SKY) and Mindfulness Based Stress Reduction (MBSR). 
 2.6.2A Sudarshan Kriya Yoga 
SKY was chosen as our primary intervention because it has been the most widely 
used breathwork in clinical studies and research.1 SKY reliably consists of three different 
types of breathing: three stage Ujjayi or victory breathing, Bhastrika or bellows 
breathing, and Sudarshan Kriya or cyclical breathing. The four components of SKY- 
three stage slow ujjayi, bhastrika, “om” chanting, and Sudarshan Kriya- are performed 
with the eyes closed while sitting in a cross legged position, and breathing in and out 
through the nostrils (see Appendix A for SKY Breathwork Components).4,71 Subjects 
within our proposed study will be taught the three components of SKY without yoga 
asanas or physical postures, om chanting, stretching, or meditation.72 This will be done in 
order to isolate the antidepressant effects of breathwork specifically. 
Within our literature review, there were deviations with the timing, frequency and 
duration of SKY as well as inconsistent incorporation of mindfulness, stress reduction 
tools, and yoga postures.1-4,73 For example, one RCT solely focused on the three types of 
SKY breathing without any other mindfulness component over a duration of four weeks, 
with daily 30-minute sessions led by an Art of Living Foundation instructor for six days 
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per week.1 Hamilton-West and colleagues (2019) incorporated SKY with mindfulness, 
stress relieving skills, and meditation.2 The study period was four weeks, similar to 
Janakiramah’s protocol (2000), but differed in frequency of sessions. A certified SKY 
instructor led four, one-hour sessions per week, with one weekend 2.5 hour workshop and 
four weekly 90 minute individual sessions for personalized feedback for all participants.  
Another clinical trial taught SKY breathwork, om chanting, and mindfulness 
skills in addition to holding weekly self-help groups within a period of two weeks, but 
extended follow-up to six months.3 There were ten, two-hour long instructor-led sessions 
for the initial two weeks, then weekly follow-up two hour sessions held for six months of 
follow-up. Participants were also expected to perform individual breathwork and 
mindfulness practices six days per week for an average duration of 20 minutes, which is 
similar to the randomized waitlist-controlled study performed by Sharma and colleagues.4 
In addition to private at-home practice, the study included yoga, mindfulness meditation, 
stress education and SKY breathwork for six 3.5-hour sessions during the first week of 
the study. Weeks 2 through 6 consisted of daily 1.5 hours of SKY training in addition to 
individual practice. Lastly, an open label study shortened the duration of SKY 
breathwork, self-reflection, meditation, yoga stretches, and stress coping strategies into 
an intensive 5-day period.73 The first day consisted of 3 hours of instruction in the three 
main forms of breathwork, which was continued onto Day 2 alongside adjunctive 
strategies for 6.5 hours. The last few days consisted of a total of 10 hours of training, with 
home practice introduced on Day 5 for 20 minutes per day for 6 days per week. This 
assortment of SKY protocols illustrates a lack of standardization and thus a limiting 
factor in the existing literature.   
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The inconsistency in SKY protocol is a limiting factor in the literature with no 
superior format determined. For this reason, we chose to match the well tolerated and 
uniform MBSR protocol to our SKY protocol. This decision will allow for equivalence in 
exposure to both interventions, and highlight what MBSR lacks, which is a breathwork 
component.  
2.6.2B Mindfulness Based Stress Reduction 
MBSR was chosen as our mindfulness-based intervention (MBI) specifically 
because it has been the most widely studied MBI and has clinically proven high patient 
tolerability and compliance rates.5,74 Originally used to treat chronic pain, MBSR has 
been applied to psychological and behavioral disorders with good effect.75  
Typically, the course is set up as an 8-week program with one instructor-led 2.5 
hour session per week. In each group session containing up to 30 people, participants are 
instructed on mindfulness meditation skills. While lying down with eyes closed during 
the body scan practice, participants focus attention on sensation from head to toe. This 
mindset is then maintained in sitting meditation.6 Lastly, Hatha yoga consists of gentle 
body awareness brought about through physical movement and stretching. Outside of one 
weekly group meeting, individuals will complete a daily 45-minute mindfulness practice 
for six days per week. Audiotapes will be used early on but gradually tapered in use. 
This standardized MBSR protocol described above was then applied to treatment 
of generalized anxiety and panic disorders fulfilling DSM-III criteria.76 A repeated 
measures analysis of variance (ANOVA) showed highly significant reduction in anxiety 
and depression from pre to post treatment. The high rate of completion (92%) and 
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maintenance of practice in 90% of patients at 3-month follow-up was encouraging for 
future studies utilizing MBIs.  
Baer and colleagues conducted a review of 22 studies using MBSR and MBCT 
for chronic pain and Axis-I disorders including depression relapse.5 Post treatment effect 
sizes ranged from 0.15 to 1.65, with an overall independent mean effect size of 0.74 (SD= 
 0.39). Mean completion rate was 85% which demonstrated the high tolerability of 
MBIs. In future studies, adequate sample sizes will be needed to assure medium to large 
effect size. Furthermore, the studies rarely reported how they ensured treatment 
completion. Our study will incorporate a daily log sheet for patients to record their 
sessions, and individual instructor feedback will help bolster treatment integrity (See 
Appendix E for Daily Log Sheet).  
Kabat-Zinn conducted the most extensive meta-analysis of MBSR program 
completion over a two-year period assessing 1,155 patients.74 Researchers measured 
completion rate and found that 76% of patients completed the eight-week intervention in 
totality with a 15% drop out rate. This meta-analysis revealed MBSR to be an effective 
with high patient compliance within a variety of somatic and psychological disorders.  
In this planned study, MBSR became the choice intervention for our mindfulness 
active control arm due to various studies demonstrating high rates of compliance, 
program completion and patient satisfaction. While a large portion of this study’s MBSR 
protocol will parallel the original established by Kabat Zinn75, our study will have one 
key differentiating factor: an online format. A meta-analysis analyzing the effectiveness 
of 15 RCTs using either websites or live virtual classrooms for MBIs in place of face-to-
face MBIs showed improvements in depression with a small significant effect size.13 A 
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pre-planned schedule with password protected links will be sent out to the MBSR as well 
as SKY group at the start of the study. Weekly live sessions will be scheduled in the 
evening hours to allow for participants’ occupational or educational commitments to be 
met first. Given the prevalence of COVID-19, necessitating social distancing to reduce 
exposure and spread of the virus, this adjustment in MBSR protocol is both necessary and 
just. 
The MBSR intervention will carry on for a period of eight weeks in total, 
matching the standard MBSR methodology. There will be one 2.5 hour session each 
week led by an instructor virtually with up to 30 people per group, who will teach three 
core mindfulness skills: full body scan, sitting meditation, and Hatha yoga. Individual 
individual practice is expected for 45 minutes per day, six days per week. Participants 
will have access to pre-recorded instructor guidance sent out via email. As is typical in 
MBSR programs, subjects will be encouraged to taper use of these audio recordings 
halfway through the intervention period. There is a one time, online 7.5 hour intensive 
workshop during the sixth week, with various days available for scheduling flexibility. 
2.6.3 Primary Outcome Measures 
 The primary outcome measure of this proposed study is mean change in the 17-
Item Hamilton Depression Rating Scale (HAM-D17) total score from baseline to post 
treatment at 8 weeks. A secondary questionnaire, the Beck Depression Inventory, Second 
Edition (BDI-II), will also be given at the same time points. The use of an objective, 
clinician rated score with a subjective, patient rated score will give greater legitimacy and 
validity to changes in depression severity due to this combined assessment of two 
perspectives.      
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The HAM-D17 is considered the gold standard in outcome measures within 
depression trials.77 The following scores will be used to differentiate depression severity: 
no depression (0-7); mild depression (8-16); moderate depression (17-23); and severe 
depression (24).78 Response will be defined as a reduction of  50% of HAM-D17 score 
obtained prior to treatment initiation, and remission will be a HAM-D17 score as  7.79 
The BDI-II is a self-report questionnaire consisting of 21 items that is one of the 
most commonly used tools to evaluate depression symptom severity.80 Importantly, all 
questions are based on DSM-IV diagnostic criteria for MDD and measured with a 4-point 
Likert scale.81 This measure has also demonstrated good internal consistency (= 0.91) 
and validated psychometric properties.80 According to the BDI-II, the following scores 
will be used to delineate depression severity: minimal depression (0-13); mild depression 
(14-19); moderate depression (20-28); and severe depression (29-63).    
2.6.4 Secondary Outcome Measure 
The secondary outcome measure will be change in FC within the DMN, 
interpreted through seed-based analysis of resting state functional connectivity MRI 
(rsfcMRI). RsfcMRI evaluates functional connectivity within predefined brain regions by 
correlating low frequency blood oxygenation level dependent (BOLD) signal changes 
(<0.1 Hz) temporally. Scans will be performed at baseline prior to intervention and 
following completion. All subjects will undergo a 5-minute fMRI scan while resting 
quietly, given no specific instruction except to close their eyes and remain still, letting 
their minds wander freely. The time period and specific wording of instructions is most 
consistent with studies using rsfcMRI to evaluate the DMN.35,54,63-65  
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Brain activity can be measured through structural, effective or functional 
connectivity.82 Functional connectivity is defined as temporal associations of 
synchronous neural activity between anatomically separate brain regions either at rest or 
during a task.51,83 The DMN is notably most active at rest without any stimuli present.26,23 
Therefore, resting state functional connectivity MRI (rsfcMRI) will be used rather than 
task-based fMRI.84   
Seed based analysis serves as a widely used method with easy interpretability for 
measuring FC. The average measurement of the time series within a seed region is 
linearly correlated with all other voxels, creating a seed-based functional connectivity 
map.85 A drawback when using seed-based analysis rather than independent component 
analysis (ICA) or graph theory is that areas of interest are restricted to predefined brain 
regions only. In our proposed study, this definition dependence is a strength as we are 
interested in a seed region integral to the DMN: the posterior cingulate cortex (PCC). 
 The PCC is the most reliable region shown to reveal FC within the DMN.51,86 In 
our study, we will use an a priori seed voxel within the PCC (x= −8, y= −56, z= 26) 
based on the Montreal Neurological Institute coordinates. This specific area was decided 
upon after an extensive review of prior fMRI studies also focusing on the DMN within a 
mood disorder patient population. Additionally, it is anatomically similar to the seed 
regions that other researchers have used to define the DMN.26,31,41,51,54,65,87,88  
 All fMRI scans will be obtained at baseline and post intervention at the 
conclusion of Week 8 on the same Siemens 3-Tesla whole body scanner at the Yale 
Magnetic Resonance Research Center. Patients will be instructed to lie in the scanner 
awake without stimuli and not think of anything in particular while their eyes are 
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closed.83 A Velcro strap placed over the forehead will reduce head motion artifact. 
Cardiac and respiratory physiologic noise will be monitored through a 
photoplethysmography on a finger of the left hand and a pneumatic belt positioned at the 
level of the upper abdomen.  
Functional MRI data will be obtained through a T*2 weighted gradient-recalled 
echo spiral pulse sequence with the following standardized parameters: repetition time/ 
echo time= 2000 msec/30 msec, flip angle= 80, 1 interleave, field of view= 200 x 200 
mm2, matrix= 64 x 64, slices= 28.35 These parameters were chosen because they mirror 
the same 5-minute interval of our resting state fMRI scan. We chose to use T*2 imaging 
rather than T*1 imaging because there is higher temporal resolution and greater 
sensitivity to blood flow and oxygenation in T*2 imaging.85  
Following imaging, physiologic noise will be removed through pre-processing 
prior to analysis. Measures of FC are highly dependent on the quality of BOLD signal. 
The signal can become distorted through artifact, such as cardiac and respiratory cycle 
noise.89,90 A type I error can occur if the noise components correlate with enough strength 
to reach threshold, yet there is no neuronal correlation. Conversely, a type II error can 
occur when there is actual temporal synchronization between the seed ROI and other 
voxels which is not found due to overlying physiologic noise.91 Pre-processing will 
consist of standard steps including slice-timing correction, motion correction, 
normalization, spatial smoothing, and linear trend removal.   
2.6.5 Confounders 
Sex, age and education are potential confounders which threaten internal validity, 
and therefore must be taken into account in order to avoid type I error.92  
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Female predominance within depression studies reflects the core concept of 
gender difference in depression.93 One meta-analysis found a 1.95 odds ratio for gender 
differences in diagnosis of MDD. Furthermore, a proportion of studies and clinical trials 
in our current literature review also demonstrated a predominance of women within 
depressed populations.2-5,13,14,94 Within the same review, age was the strongest predictor 
of effect size, with a peak of effect size in adolescence that stabilized in adulthood. 
Initially, our RCT study design will reduce potential confounding effects via 
randomization and creating groups that are adequately comparable in terms of potentially 
confounding variables and size. In addition, analysis of covariance (ANCOVA) will be 
applied to increase statistical power after data collection.  
2.7 Conclusion  
 This current literature review demonstrates the unique application and potential 
effectiveness of both SKY and MBSR as adjunctive antidepressant therapies, measured 
through symptomatic relief and change in DMN FC through rsfcMRI. Depression affects 
all age groups and is highly prevalent condition within the COVID-19 pandemic. We 
have outlined areas for improvement within the current studies available concerning the 
variables of this study, which our proposed study will address. Analysis of these studies 
illustrated the components of our study design and the necessity of this study as we seek 
to offer and expand current options for treatment of depression. Ultimately, this study 
will add to the current literature focusing on non-pharmacological adjuvant treatment 
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CHAPTER 3: STUDY METHODS 
3.1 Study Design  
 We will conduct a prospective, randomized controlled trial (RCT) to determine if 
there is a change in depression symptom severity and, secondarily, change in functional 
connectivity in the Default Mode Network (DMN). The sample consists of adults with 
mild to moderate major depressive disorder (MDD) aged 18 – 65 years old who are 
randomized into one of three groups. The experimental treatment group will participate in 
Sudarshan Kriya Yoga (SKY) as their adjunctive therapy in addition to their current 
pharmacological regimen. An adjunctive care group will receive the established and 
standardized Mindfulness Based Stress Reduction (MBSR) therapy in addition to their 
current pharmacological regimen. A standard care group will continue to receive their 
current pharmacological therapy. The goal is to examine change in symptoms of 
depression within and between the three groups to investigate feasibility and efficacy of 
adjunctive nonpharmacological treatments. Potential confounders, including sex, age, and 
education, will be adjusted for in the study design and analysis.   
3.2 Study Population and Sampling  
 The source population in this study is adults aged 18-65 years old with mild to 
moderate depression, as defined by the diagnostic criteria as set forth by the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). From the pool of 
subjects who respond to study recruitment efforts through an intake form, we will utilize 
 47 
convenience sampling based on meeting all inclusion criteria and no exclusion criteria 
until an adequate sample size is reached during rolling enrollment. Once an adequate 
sample size is reached, researchers will use online software to block randomize subjects 
into each of the three study groups in order to have equal group size. (See Appendix F for 
Intake Form).    
3.2.1 Inclusion Criteria  
 Subjects will be adult outpatients aged 18-65 years old. All participants will be 
assessed by a psychiatrist or clinical psychologist to meet criteria for mild-moderate 
major depression (MDD), as the goal of the study is to investigate adjunctive, 
nonpharmacological therapy in patients who continue to have symptoms of depression in 
the mild-moderate range despite their current pharmacological regimen. The criteria for 
inclusion are:  
1) Current diagnosis of MDD for at least 2 years.  
2) Fulfillment of criteria according to the Structured Clinical Interview for 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID for DSM-
IV) for a single or recurrent major depressive episode.  
3) Have current self-reported mild-moderate depression symptoms within a total 
score range of 8-23 for the 17-item Hamilton Depression Rating Scale (HAM-D17) and a 
range of 14-28 for the Beck Depression Inventory, Second Edition (BDI-II).  
4) All participants will need to be on a stable ( 8 weeks) dose of 
antidepressant(s). If a pharmacological regimen is changed, participants can continue in 
the study but may be removed from study analysis as appropriate.  
5) Must be right-handed. 
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6) Must have access to a personal smart phone, computer, or tablet to access 
remote online sessions. 
3.2.2 Exclusion Criteria   
   The exclusion criteria for the selected study population includes any comorbid 
Axis I disorders, bipolar disorder, psychosis, alcohol or substance abuse within the past 6 
months, contraindications to MRI (e.g., metallic implants, pacemakers, or 
claustrophobia), active suicidality, seizure disorder, history of head injury that resulted in 
loss of consciousness, neurological disorder, brain degenerative disease, history of 
electroconvulsive therapy, history of transcranial magnetic stimulation, history of stroke 
or significant head injury, and current yoga, meditation or breathwork practices. 
3.3 Recruitment     
 Participants will be recruited through IRB approved flyer callouts posted 
throughout Yale University Undergraduate and Graduate campuses to advertise to the 
university student population. Bulletin board advertisements will also be posted at 
specialty outpatient clinics, including the Connecticut Mental Health Center and Cornell 
Scott-Hill Health Center, to advertise to a more diverse clinical population and to offer 
nonpharmacological, remote treatment options to the greater New Haven community. See 
Appendix D for sample recruitment flyer. 
3.4 Subject Protection and Confidentiality  
This will be an Institutional Review Board (IRB)-approved, Health Insurance 
Portability and Accountability Act (HIPAA)-compliant prospective randomized 
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controlled trial. This study will obtain informed, written consent from each participant 
that explicitly describes the group treatment sessions (See Appendix G). Participants will 
be informed that during live remote video sessions for both MBSR and SKY, an 
instructor will be teaching a group of less than 30 individuals. No sessions will ever be 
recorded, and a password protected link will be sent out for each session. Participants 
have the option of keeping their videos on in order to receive feedback. All members of 
the research team will complete the Human Subjects Protection Training and HIPAA 
Privacy training. No members will have external financial or non-financial interests 
related to the research which may affect the protection of individuals volunteering for 
research. Patient information will be protected through exclusive access on secure, 
password encrypted institutional servers. Each participant will be given an ID code to 
protect privacy. Participants will know explicitly what information will be used for 
research purposes and be informed of our confidentiality and privacy practices.  
Given that this study will be advertised within the undergraduate and graduate 
Yale University campus grounds, all requirements will be fulfilled in accordance with 
Yale IRB Policy 350 Participation of Yale Students, Fellows, Trainees, or Employees in 
Research. Additionally, we will fulfill requirements when obtaining clear, informed 
consent as set by the Yale IRB Policy 200 Informed Consent for Human Research. The 
consent form will fully explain the purpose of this study and anticipated study duration, 
emphasizing the group format of the study, identifying pertinent procedures with ensuing 
comprehensive descriptions, and detailing the subject risk and benefits. The participants 
will be made aware that participation is completely voluntary and that they can withdraw 
at any point during the study without consequence. Contact information will be provided 
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should subjects have any questions, comments or concerns. Final submission of the 
necessary IRB forms will be made using the IRES IRB system. 
3.5 Study Variables and Outcome Measures 
3.5.1 Independent Variables  
The independent variables in this study are SKY and MBSR as adjunctive 
therapies to standard, stable dose antidepressant treatment for MDD. The mindfulness 
intervention, MBSR, will be based on the original protocol developed by Kabat-Zinn, 
with relatively minimal changes to adapt to an online context.1 Meditation sessions will 
be led by a certified MBSR teacher conducted through live remote video. The 
intervention duration will be for 8 weeks, weekly 2.5 hours group with less than 30 
people per group. These sessions will be complemented with an independent at-home 
practice approximately 45 minutes per day for 6 days per week, as well as a day-long 
online mindfulness retreat on the sixth week of the intervention (9am-4pm). The SKY 
protocol will mirror the MBSR administration. It will also be taught via live remote video 
sessions, where once again participants have the option of turning their videos or 
microphones on if desired in order to receive feedback from the instructor. A trained 
SKY instructor from the Art of Living Foundation will lead participants through the main 
SKY breathing techniques once per week for 2.5 hours, which is structurally equivalent 
to the MBSR protocol. Participants will perform breathwork independently 45 minutes 
per day for 6 days per week, and also participate in an online day long retreat during the 
sixth week consisting of intensive breathwork and individual feedback (9am-4pm). The 
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specific elements of both MBSR and SKY interventions have been described previously 
in detail (see Chapter 2). 
3.5.2 Primary Dependent Variable  
 The primary dependent variable is change in severity of depression symptoms, as 
measured by the clinician-rated 17-Item Hamilton Depression Rating Scale (HAM-D17) 
which controls for observation bias, and secondarily by the self-rated Beck Depression 
Inventory, Second Edition (BDI-II). The questionnaires are completed at baseline (Week 
0) and again at the end of the study (Week 8). The HAM-D17 will utilize the following 
scoring: severe depression (≥24), moderate depression (17-23), mild depression (8-16), 
and no depression (0-7).2 The BDI-II consists of 21 questions which are self-completed 
and consistent with the DSM-IV criteria used to both diagnose and treat depression. The 
following established scoring will be used: severe depression 29–63, moderate depression 
20–28, mild depression 14–19, and minimal depression 0–13.3  
3.5.3 Secondary Dependent Variable  
  The second aim of this study is to examine how the two adjuvant treatments- SKY 
and MBSR- effect functional connectivity (FC) within the DMN, in comparison to 
isolated standard pharmacological therapy. Therefore, the secondary outcome of interest 
in this study will be change in FC of the DMN within each group as well as across all 
three groups. Participants will undergo a 5-minute resting state functional connectivity 
MRI (rsfcMRI) scan performed at Week 0 (baseline) and post assessment at the end of 
Week 8 to assess for change over time on the same Siemens 3-Tesla whole-body MRI 
scanner. Changes in functional connectivity within the DMN will be assessed using an a 
 52 
priori defined posterior cingulate cortex (PCC) (x=-8, y=-56, z=26) as primary seed 
region of interest (ROI) for seed-based functional connectivity analysis.  
3.5.4 Potential Confounding Variables  
 Possible confounding variables within this study include sex, age and education 
level. An advantage of the block randomization RCT design is to minimize the effects of 
possible confounding variables. However, as this cannot be guaranteed and confounders 
may influence the results of the study, an analysis of covariance (ANCOVA) statistical 
approach will be utilized to account for potential effects of these confounders.4 
3.6 Methodology Considerations 
 3.6.1 Blinding  
 It is not possible to double-blind this proposed study, as explicit patient 
participation in SKY and MSBR is required. However, there are other opportunities to 
incorporate blinding methods into the study design and elements. For example, SKY and 
MBSR instructors will only be exposed to people who are in their respective groups. 
These teachers will not know the randomized data number assigned to each participant 
nor will they be involved in data analysis. In addition, the clinician who is rating the 
HAM-D17 questionnaire at the beginning and conclusion of the study will not know 
which group the subject was randomized to and will not be involved in treatment 
administration. Patients will also be informed to not tell the outcome assessor which 
treatment they received. 
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3.6.2 Assignment of Intervention 
 Following meeting the inclusion and none of the exclusion criteria, eligible 
participants will be randomly assigned to either intervention group or continue their 
stable antidepressant regimen. Block randomization will then be carried out to allow for 
an equal number of subjects per group. The randomization software will be completed by 
a computer specialist external to the study.   
3.7 Data Collection 
Methods for data collection include questionnaires, such as the HAM-D17 and 
BDI-II, and neuroimaging data acquired from rsfcMRI scans. Initially, participants will 
fill out an intake form that will obtain name, age, sex, race/ethnicity, birth date, highest 
level of education achieved, and the type, frequency, and duration of antidepressant 
medications that are being taken. Other considerations, including exclusion criteria, will 
also be assessed through this intake form. All participants will undergo a standardized 
psychiatric evaluation using the SCID for DSM-IV. They will complete the clinician 
rated HAM-D17 as well as the self-administered BDI-II in order to get a convergence of 
object and subjective perspectives. All subjects will also undergo rsfcMRI scans at the 
baseline and conclusion of the study. These scans will be performed on the same Siemens 
3-Tesla MRI scanner at the Yale Magnetic Resonance Research Center, which is in close 
proximity to the academic campuses, medical centers, and community from which our 
participants will be recruited from. Lastly, participant compliance with home practice will 
be assessed based on self-completed participant log sheet records that will be collected at 
the end of the study.  
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3.8 Sample Size Calculation        
 The calculation for our sample size was performed using the G*Power version 3.1 
with ANCOVA to compare change in pre-intervention and post-intervention HAM-D17 
total scores given the confounders of sex, age, and education level. The reviewed 
literature is typically powered based on the primary outcome measure to a significance 
level of 5% and power of 80%, which our study will follow. We utilized a medium effect 
size, consistent with the studies reviewed also using similar outcome measures.5-7 Our 
sample size was initially calculated to be 196 participants. We do anticipate a 10% drop 
out rate, which led to a sample size of 213 participants. Reasons for drop out will be 
recorded and tracked to identify any patterns of drop out that could potentially impact 
results.8 Our complete sample size calculation can be found in Appendix H. 
3.9 Statistical Analysis  
Intention to treat (ITT) analysis will be used to analyze results in this prospective 
RCT. Initially, baseline demographic characteristics that are continuous or dichotomous 
in nature, including sex, age, and education levels of all enrolled participants, will be 
analyzed using a chi-squared test. A correlation matrix will illustrate the cross 
correlations between demographic variables and depression ratings.  
3.9.1 Primary Outcome 
Mean total HAM-D17 and BDI-II scores with standard deviation will be obtained 
from each of the three groups both pre and post intervention. Paired t-tests will be used to 
assess significant difference in depression symptom severity within each group based on 
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mean difference in total HAM-D17 scores as primary outcome, and each t-test will be 
two-sided with a significance of p< 0.05. In order to assess significant change in 
depression symptom severity based on HAM-D17 between the three groups post-
intervention, ANCOVA will be performed with group as between subject factor and 
baseline subject characteristics of sex, age and education level as covariates. The same 
procedure will be repeated for the BDI-II questionnaire mean total scores.  
3.9.2 Secondary Outcome 
Functional connectivity changes within the DMN using the posterior cingulate 
cortex (PCC) as the seed region of interest (ROI) (x=-8, y=-56, z=26) will be analyzed 
through seed-based analysis both within and between each of the three groups at baseline 
(Week 0) and the conclusion of the study at the end of Week 8. We will obtain average 
time series from within the seed region and use the Pearson correlation coefficient to 
capture linear, temporally dependent BOLD signal changes that indirectly reflect 
synchronized activity between the PCC and other brain regions.9 We will then z-
transform all functional connectivities with a Fisher’s r-to-z transformation for normal 
distribution. The resultant connectivity map will show all voxels that had a significant 
time dependent neural activity correlation with the PCC and thus reflect the strength of 
functional connectivity, with a false discovery rate of 0.05 (pFDR <0.05).
10,11   
Within group analysis will next be done by entering z-scores into a series of one-
sample t-tests in SPM 12, comparing baseline and post-intervention scans with a 
significance threshold of p< 0.05 (FDR corrected) for each group. This will determine 
cortical regions with statistically significant association with the PCC seed ROI within 
each of the three groups of participants after treatment completion. 
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Secondly, between group analysis of FC will be accomplished using ANCOVA 
with group as between subject factor and sex, age and education level as covariates 
(p<0.05, FDR corrected, minimum 21 voxels in a cluster). ANCOVA has the lowest 
variance, highest power, and nominal 95% CI coverage relative to ANOVA-POST and 
ANOVA-CHANGE, making it the preferred analytical tool.4  
3.9.3 Image Pre-Processing 
Images will be pre-processed using the Statistical Parametric Mapping Software, 
Version 12 (SPM 12), including slice-timing correction using sinc interpolation, 3D 
motion correction using sinc interpolation, normalization into the Montreal Neurological 
Institute space, and spatial smoothing with a 3D Gaussian kernel (full-width-at-half-
maximum of 4 mm).10,12 These measures will suppress high frequency signals that reflect 
spatial noise as well as enhance low frequency signals within the .01 Hz to .08 Hz range, 
and lastly result in linear trend removal. Subjects who have excessive head motion 
(>2.5mm translation or > 5 rotation) will be excluded from future analysis.12 The first 
five images will be discarded to allow for magnetic equilibrium and discard magnetic 
saturation. 
Physiological noise from cardiorespiratory components will be monitored through 
a photoplethysmography placed on the finger of the left hand and a pneumatic belt 
positioned at the level of the upper abdomen. Cardiac and respiratory artifact will be 
removed using the RETROICOR algorithm and by removing low-frequency respiratory 
rate and heart rate effects.13,14  
3.10 Timeline and Resources  
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 Pending IRB approval, the study will be completed within 2 years, encompassing 
patient recruitment and protocol completion. After interested participants contact the 
research team through an email which will be listed on all IRB approved flyers, an online 
screening will be done to determine eligibility. Screen consists of an intake survey 
detailing their name, age, gender, level of education, psychological disorders, frequency 
and dosage of any antidepressant medications, and exclusion criteria (See Appendix F for 
Intake Form). A clinical psychologist or psychiatrist will administer the SCID for DSM-
IV and the patient will complete the BDI-II. We will use a rolling enrollment period of 12 
months or until the calculated sample size of 213 is reached. Following signature of an 
informed consent form upon enrollment, participants will be block randomized into one 
of three groups: pharmacological therapy with SKY, pharmacological therapy with 
MBSR, or continuing standard pharmacological therapy without adjunctive therapy 
(serving as control). All adults will be educated on the use of password protected links for 
either MBSR or SKY, as well as given flexible time slots to obtain baseline fMRI 
imaging. Data analysis will be completed within 2-3 months following completion. 
 Personnel to be included in this study include a principal investigator, a co-
principal investigator, clinical psychologist or psychiatrist to rate baseline and post 
intervention HAM-D17 questionnaires, a computer specialist to randomize eligible 
subjects, Yale Magnetic Resonance Research center lab assistant to run rsfcMRI scans, 
fMRI imaging analyst, a certified SKY instructor, and a certified MBSR instructor. There 
will also be one physician associate student to aid in recruitment, data analysis, and 
statistical analysis.  
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CHAPTER 4: CONCLUSION 
 4.1 Advantages  
When reflecting on our study’s advantages, the prospective, randomized 
controlled trial (RCT) design reduces bias through randomization. The most relevant 
strength of the experimental intervention of this study- Sudarshan Kriya Yoga (SKY)- 
lies in the fact that breathwork is both an economically sound and socially just practice. 
SKY could be used to stabilize a patient’s current treatment, decreasing the number of 
prescriptions which enable financial savings.1,2  
This practice can be used on a multitude of patients, including those with physical 
disability. It is easy to administer across urban, suburban, and rural regions given the 
online format of the intervention. Once the basic cadence of breathwork is memorized, 
then the patient can proceed at leisure in terms of deciding when to practice, with no need 
to travel anywhere, take time off work, or find childcare. 
The study design will establish a potential standardized SKY protocol, as the 
current literature reviewed by researchers was inconsistent. Furthermore, matching the 
SKY protocol to the well-established and tolerated Mindfulness Based Stress Reduction 
(MBSR) protocol will allow for equivalence in the exposure to the interventions in our 
study. The design is also feasible for future studies due to its online format. No in-person 
MBSR or SKY sessions will be required, allowing participants to complete their assigned 
intervention in the comfort of their own homes. In addition, focusing specifically on 
depression during the COVID-19 pandemic is especially pertinent given rising isolation 
and prevalence of depression.3 Increased prevalence of depression may persist while 
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COVID-19 health and safety policies remain, which highlights the relevance of an at 
home, easy to use, individual practice like SKY. 
4.2 Disadvantages 
Although this study contains significant advantages in terms of study design and 
contribution to the current literature, there are some limitations. Convenience sampling is 
nonrandomized, resulting in potential selection bias and lower external validity. 
Furthermore, the target patient population was specified to those mild-moderate 
depression already on antidepressant medications within the Yale Health System and 
greater Connecticut areas.  This study was designed to exclude severely depressed 
patients because they are often refractory to typical treatment and require escalation to 
high intensity therapies.4 Our study may have lower external validity, as the patient 
population is not completely representative of the entire population of depressed 
individuals. However, if this intervention is found to be successful in the selected mild-
moderate population, we would think carefully about how this intervention could be 
assessed safely in a population with severe depression, such as in an inpatient setting. 
The study protocol will control for physiologic noise during rsfcMRI scans through a 
photoplethysmography and pneumatic belt. However, it does not control for participant 
related factors that could have affected BOLD signal. The vasoconstrictive effect of 
caffeine affects cerebral blood flow which in turn alters BOLD signal.5 Aside from 
caffeine, intake of food, nicotine, and alcohol before a resting state fMRI scan can have 
significant effects on BOLD signal. Given that MRI times will be scheduled throughout 
the day, the researchers did not want to be overly restrictive to a vulnerable population.  
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Lastly, treatment adherence is a common threat to MBI effectiveness.6,7. Non-
adherence occurs when participants do not complete the intervention in entirety with the 
minimum frequency as defined in study protocol. Regular practice is essential to obtain 
ultimate benefit.8 Although the study participants will complete a self-reported daily log, 
it might be more accurate to have researcher personnel observed SKY or MBSR sessions 
to ensure completeness and accuracy. Future studies without the current social distancing 
requirements and COVID-19 health and safety conditions could implement therapists to 
observe or lead individual practice sessions.   
4.3 Clinical Significance  
This study is clinically significant because it examines the effectiveness of an 
adjunctive treatment for MDD and can broaden our understanding of the underlying 
mechanisms amongst breath-oriented therapy, depression, and functional connectivity 
within the brain. If this study demonstrates effectiveness and high patient tolerability with 
SKY, breathwork could become more widely accessible for patients, especially those 
undergoing financial hardship and already at risk for health disparities. Instead of 
increasing dosage of antidepressants, SKY could be added as a low risk, low cost 
adjunctive treatment to work in conjunction with the medications. In conclusion, 
improving availability of treatment options and programs for individuals with mild to 
moderate depression can reduce escalation of treatment, reduce relapse rates, and result in 
greater rates of remission.9 This study has the potential to improve treatment options for 
those with MDD through a cost effective and individually empowering additional 
remedy: breathwork. 
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Appendix A: Sudarshan Kriya Yoga Breathwork Components 
 
Practice Breath Rate (cycles/min, 
cpm)a 
Duration (minutes)b 
3-stage victory breathing 2-4 cpm 7 minutes 
Bellows breathing/ 
Bhastrika 
30-40 cpm 3 minutes 
Sudarshan Kriya cyclical 
breathing 
8-180 cpm 10 minutes 
Rest Period N/A  5 minutes 
a Approximate range 



















































Appendix D: Recruitment Flyer  
 
Volunteers Needed for Participation in Research Study  
We are investigating the incorporation of Sudarshan Kriya Yoga breathwork as well as 
Mindfulness Based Stress Reduction in addition to antidepressants for treatment of mild 
to moderate major depressive disorder. 
 
Who can participate? 
Adults aged 18-65 years old with a diagnosis of mild to moderate depression currently on 
antidepressant medications.  
 
What will be asked of you? 
You will be asked to participate in an online, certified instructor led, randomized 
additional treatment option- either Sudarshan Kriya Yoga breathwork or Mindfulness 
Based Stress Reduction- or continue your current antidepressant medication for a period 
of 8 weeks with daily practice sessions required. You will undergo an fMRI scan both 
before and after the intervention, as well as participate in 2 surveys to determine change 
in depression severity following completion of the study. 
 
If you are interested in participating or have any 
questions, please do not hesitate to contact us at: 




Appendix E: Daily Log Sheet 
 
Week Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
Week 1        
Week 2       
Week 3        
Week 4       
Week 5       
Week 6       
Week 7       



















Appendix F: Intake Form 
Name: _________________________ 
Participant ID code: ________ 
Date: __/__/____ 
Age: ___  
 
Gender:      Male        Female  
Education:       
o No high school diploma   
o High school diploma 
o Associate’s degree or 2 years of college 
o Bachelor’s degree 
o Master’s degree 
o PhD or professional degree  
When were you diagnosed with major depressive disorder?  
o < 2 years ago 
o > 2 years ago  
Duration of current depressive episode 
o < 1 week 
o 1-2 weeks 
o 2-3 weeks 
o 3-4 weeks 
o 1 month 
o 2 months 
o 3 months  
o 4 months 
o 5 months 
o 6 months  





Are you right-handed?     Yes    No  
Do you have access to a personal smart phone, computer, or tablet?    Yes    No 
Are you currently being treated for any other mood disorder?       Yes       No  
- If “yes”, please write down which other disorder: ______________________________ 
Do you have Bipolar disorder?   Yes       No 
Have you ever experienced psychosis? Yes       No 
Any excessive alcohol or substance use within the past 6 months? Yes       No 
Do you have any metallic implants or a pacemaker? Yes       No 
Are you claustrophobic? Yes       No 
Are you currently being managed for active suicidal thoughts?  Yes       No 
Do you have a seizure disorder? Yes       No 
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Any history of head injury or trauma that resulted in a loss of consciousness?  
Yes       No 
Do you have any neurological disorders?             Yes       No 
Do you have a brain degenerative disease? Yes       No 
Have you undergone electroconvulsive therapy before or transcranial magnetic 
stimulation?        Yes       No 
Any history of stroke or significant head injury?     Yes       No 




TO BE COMPLETED BY RESEARCHER: 
HAM-D 17 total score, baseline: ________ 


















Appendix G: Written Consent Form 
WRITTEN CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT  
Study Title: Sudarshan Kriya Yoga and Alteration in Depression Severity and Default 
Mode Network Connectivity 
Principal Investigator: Dr. Emily Sharp 
Co-Principal Investigator: Elizabeth Togneri   
Affiliation: Yale University School of Medicine, Connecticut Mental Health Center, & 
Cornell Scott-Hill Health Center  
 
Invitation to Participate and Description of Project 
We are inviting you to participate in a research study designed to look at change in 
depression severity and brain activity following three different interventions. You were 
selected because you are currently undergoing pharmacological treatment for depression. 
Approximately 213 individuals will participate in this study. Every individual will be 
randomized to one of three groups: Sudarshan Kriya Yoga (SKY) breathwork alongside 
antidepressants, Mindfulness Based Stress Reduction (MBSR) with antidepressants, or 
only continuing antidepressants. Change depression symptom severity as well as brain 
functional connectivity via fMRI scans will be compared amongst these groups after 8 
weeks.  
In order to decide whether or not you wish to be a part of this research study you should 
know enough about its risks and benefits to make an informed decision. This permission 
form gives you detailed information about the study, which a member of the research 
team will discuss with you. This discussion should go over all aspects of this research: its 
purpose, the procedures that will be performed, any risks of the procedures, and possible 
benefits. Once you understand the study, you will be asked if you wish to participate; if 
so, you will be asked to sign this form.  
 
Description of Procedures 
If you agree to participate in this study, you will be asked to undergo an fMRI scan both 
prior to the start of the study and at the conclusion of the study at approximately 8 weeks.  
After signing the consent form, you will be contacted by a researcher to complete two 
surveys. One will be completed on your own time and is called the Beck Depression 
Inventory, Second Edition. A second survey will be administered by a clinician who will 
ask you a number of questions concerning your depression which is called the 17-Item 
Hamilton Depression Rating Scale. Both surveys will be completed again at the 
conclusion of the study. 
 
 73 
You will also be randomized into one of the three aforementioned groups. All group 
participants will continue their current antidepressant regimen per usual. If you are 
assigned to the first group, you will be instructed in basic breathwork skills according to 
Sudarshan Kriya Yoga (SKY). If you are assigned to the second group, you will 
participate in meditation sessions according to Mindfulness Based Stress Reduction 
Protocol and also continue your antidepressant regimen. If you are assigned to the third 
group, you will only continue your antidepressant medications. You will be sent a 
confidential, password protected link to participate in online training for either group 
which has an additional treatment, either breathwork or mindfulness skills.  
If you are randomized to the Sudarshan Kriya Yoga group, you will have one 2.5 hour 
session led by a certified instructor during Week 1 who will teach the basic breathwork 
skills. You will then be expected to practice breathwork 45 minutes per day, six days 
each week. Lastly, you will attend a 7.5 hour workshop during Week 6, also held online. 
If you are assigned to the MBSR group, you will undergo the same time commitment as 
above, but be taught by a different instructor who specifies in full body scan practice, 
sitting meditation, and Hatha yoga.  
The purpose of this survey is to evaluate whether nonpharmacological adjunctive 
treatments can improve depression severity and alter functional connectivity in the brain. 




Risks and Inconveniences 
 
Magnetic resonance (MR) is a technique that uses magnetism and radio waves, not x-
rays, to take pictures and measure chemicals of different parts of the body.  The United 
States Food and Drug Administration (FDA) has set guidelines for magnet strength and 
exposure to radio waves, and we carefully observe those guidelines.   
 
You will be watched closely throughout the MR study. Some people may feel 
uncomfortable or anxious.  If this happens to you, you may ask to stop the study at any 
time and we will take you out of the MR scanner.  On rare occasions, some people might 
feel dizzy, get an upset stomach, have a metallic taste or feel tingling sensations or 
muscle twitches.  These sensations usually go away quickly but please tell the research 
staff if you have them.   
 
There are some risks with an MR study for certain people.  If you have a pacemaker or 
some metal objects inside your body, you may not be in this study because the strong 
magnets in the MR scanner might harm you.  Another risk is the possibility of metal 
objects being pulled into the magnet and hitting you.  To lower this risk all people 
involved with the study must remove all metal from their clothing and all metal objects 
from their pockets.  We also ask all people involved with the study to walk through a 
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detector designed to detect metal objects.  It is important to know that no metal can be 
brought into the magnet room at any time.  Also, once you are in the magnet, the door to 
the room will be closed so that no one from outside accidentally goes near the magnet. 
 
We want you to read and answer very carefully the questions on the MR Safety 
Questionnaire related to your personal safety.  Take a moment now to be sure that you 
have read the MR Safety Questionnaire and be sure to tell us any information you think 
might be important.   
 
This MR study is for research purposes only and is not in any way a healthcare 
examination of the brain.  The scans performed in this study are not designed to find 
abnormalities.  The principal investigator, the lab, the MR technologist, and the Magnetic 
Resonance Research Center are not qualified to interpret the MR scans and are not 
responsible for providing a healthcare evaluation of the images.  If a worrisome finding is 
seen on your scan, a radiologist or another physician will be asked to review the relevant 
images.  Based on his or her recommendation (if any), the principal investigator or 
consulting physician will contact you, inform you of the finding, and recommend that 
you seek medical advice as a precautionary measure.  The decision for additional 
examination or treatment would lie only with you and your physician.  The investigators, 
the consulting physician, the Magnetic Resonance Research Center, and Yale University 
are not responsible for any examination or treatment that you receive based on these 
findings.  The images collected in this study are not a healthcare MR exam and for that 
reason, they will not be made available for healthcare purposes.   
Recording daily MBSR meditation sessions and SKY breathwork sessions may come as 
an inconvenience to you. Researchers will be available for questions at any time and 
encourage your full participation.  
You may be uncomfortable revealing personal information in participant surveys. Every 
effort will be made to keep your information confidential. A breach of confidentiality is 
unlikely to occur, as all study investigators are trained in research privacy.  
  
Benefits 
This study aims to evaluate whether depression severity can be further relieved by 
supporting individuals through breathwork or mindfulness based tactics. There may be 
direct benefit for you from participation in gaining a new skill and tool, whether it is 
breathwork or stress reduction techniques, to help with depressive symptoms. Your 
participation may also forward research to help many others also suffering from 




Appropriate alternative options regarding therapy and diagnostic options include 
speaking with your primary care provider or psychiatrist regarding current medication 
dosages, as well as declining to participate in this study.  
 
Confidentiality 
We understand that information about your health is personal, and we are committed to 
protecting the privacy of that information. Any identifiable information that is obtained in 
connection with this study will remain confidential and will be disclosed only with your 
permission or as required by U.S. or State Law. Examples of information that we are 
legally required to disclose include abuse of a child or elderly person, or certain 
reportable diseases.  Information will be kept confidential by using identification 
numbers on study forms, storing signed forms in locked cabinets and password protecting 
data stored on a computer. When the results of the research are published or discussed in 
conferences, no information will be included that would reveal your identity unless your 
specific permission for this activity is obtained.  
Representatives from the Yale Human Research Protection Program, the Yale Human 
Investigation Committee (the committee that reviews, approves, and monitors research on 
human subjects) may inspect study records during internal auditing procedures.  However, 
these individuals are required to keep all information confidential.  
By signing this form, you authorize the use and/or disclosure of the information described 
above for this research study. The purpose for the uses and disclosures you are 
authorizing is to ensure that the information relating to this research is available to all 
parties who may need it for research purposes.  
All healthcare providers subject to HIPAA (Health Insurance Portability and 
Accountability Act) are required to protect the privacy of your information. The research 
staff at the Yale School of Medicine are required to comply with HIPAA and to ensure 
the confidentiality of information.  
 
Voluntary Participation and Withdrawal 
 
Participating in this study is voluntary. You are free to choose not to take part in this 
study.   Refusing to participate will involve no penalty or loss of benefits to which you 
are otherwise entitled (such as your health care outside the study, the payment for your 
health care, and your health care benefits).  However, you will not be able to enroll in this 
research study and will not receive study procedures as a study participant if you do not 
allow use of your information as part of this study. 
 
Withdrawing From the Study 
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If you do become a subject, you are free to stop and withdraw from this study at any time 
during its course. This will cancel any future MRI appointments and evaluation of 
depressive symptoms based on surveys. To withdraw from the study, you can call or 
email a member of the research team at any time and tell them that you no longer want to 
take part.   
 
The researchers may withdraw you from participating in the research if necessary.  
 
Withdrawing from the study will involve no penalty or loss of benefits to which you are 
otherwise entitled.  It will not harm your relationship with your own doctors or with the 
Connecticut Mental Health Center and the Cornell Scott-Hill Health Center. 
 
When you withdraw from the study, no new health information identifying you will be 
gathered after that date.  Information that has already been gathered may still be used and 
given to others until the end of the research study, as necessary to insure the integrity of 




We have used some technical terms in this form.  Please feel free to ask about anything 
you don't understand and to consider this research and the consent form carefully – as long 




I have read (or someone has read to me) this form and have decided to participate in the 
project described above.  Its general purposes, the particulars of my involvement and 
possible hazards and inconveniences have been explained to my satisfaction.  My signature 















Signature of Principal Investigator  Date 
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                                      or 
 
___________________________________________ ___________________ 
Signature of Person Obtaining Consent  Date 
 
 
If you have further questions about this project or if you have a research-related problem, 
you may contact the Co-Principal Investigator, Elizabeth Togneri. 
If, after you have signed this form you have any questions about your privacy rights, 
please contact the Yale Privacy Officer at 203-432-5919. If you would like to talk with 
someone other than the researchers to discuss problems, concerns, and questions you may 
have concerning this research, or to discuss your rights as a research subject, you may 


















Appendix H: Sample Size calculation 
The sample size was calculated* using the following parameters 
Alpha= 0.05 (2-sided hypothesis) 
Power= 0.80 







*Calculated using G*Power version 3.1 with ANCOVA 
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